Join our
Investor Newsletter

To receive Investor News as it is released please sign up

News Releases

Joint program with American Diabetes Association

January 4, 2022
RNS Number : 2538X Renalytix PLC 04 January 2022   Renalytix plc ("Renalytix" or the "Company")   American Diabetes Association and Renalytix Partner to Prioritize Kidney Health in Type 2 Diabetes Population   National program establishes early care management, technology innovation and large

Result of AGM

December 17, 2021
RNS Number : 0925W Renalytix PLC 17 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Result of AGM   LONDON and SALT LAKE , 17 December 2021   - Renalytix (NASDAQ: RNLX)  (LSE: RENX) announces that at the Annual General Meeting ("AGM") held earlier today, all resolutions were

Director/PDMR Shareholding

December 17, 2021
RNS Number : 0593W Renalytix PLC 17 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 17 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by Ann Berman , the Company's Non-Executive Director, of 3,000

Director/PDMR Shareholding

December 13, 2021
RNS Number : 3617V Renalytix PLC 13 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 13 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of

Director/PDMR Shareholding

December 9, 2021
RNS Number : 1070V Renalytix PLC 09 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 9 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase of 4,805 American Depositary Shares (" ADS ") by certain members of

Director/PDMR Shareholding

December 8, 2021
RNS Number : 9024U Renalytix PLC 08 December 2021   Renalytix plc (" Renalytix " or the " Company ")     Director/PDMR Dealing   New York , 8 December 2021 - Renalytix (LSE: RENX) announces that it has been advised of the purchase by James McCullough , the Company's Chief Executive Officer, of 950

Renalytix Reports Financial Results for Q1 of FY22

December 7, 2021
RNS Number : 7546U Renalytix PLC 07 December 2021     Renalytix plc ("Renalytix" or the "Company")   Renalytix Reports Financial Results for First Quarter of Fiscal Year 2022   LONDON and SALT LAKE CITY , December 7, 2021   - Renalytix plc (NASDAQ: RNLX) (LSE : RENX), an artificial

Notice of Q1 FY22 Results

December 2, 2021
RNS Number : 2978U Renalytix PLC 02 December 2021     Renalytix plc ("Renalytix" or the "Company")   Renalytix to Report First Quarter Fiscal Year 2022 Financial Results on December 7   LONDON and SALT LAKE CITY , December 2, 2021 -- Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the

Publication of Annual Report 2021 & Notice of AGM

November 19, 2021
RNS Number : 0262T Renalytix PLC 19 November 2021     Renalytix plc ("Renalytix" or the "Company")   Publication of Annual Report 2021 and Notice of 2021 Annual General Meeting   LONDON and SALT LAKE CITY , November 19, 2021 - Renalytix plc (NASDAQ: RNLX) (LSE: RENX) announces that the Annual

Renalytix Convenes Panel at VA Healthcare Summit

November 10, 2021
RNS Number : 8663R Renalytix PLC 10 November 2021     Renalytix plc ("Renalytix" or the "Company")   Renalytix Convenes Expert Panel at VA Healthcare Summit   Leading clinicians discuss enabling long-term kidney health in Veterans with type 2 diabetes and early-stage chronic kidney disease   NEW
Displaying 31 - 40 of 209